tiprankstipranks
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily

Blueprint Medicines (BPMC) Income Statement

541 Followers

Blueprint Medicines Income Statement

Last quarter (Q3 2024), Blueprint Medicines's total revenue was $128.18M, an increase of 126.61% from the same quarter last year. In Q3, Blueprint Medicines's net income was $-56.28M. See Blueprint Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 434.41M$ 249.38M$ 204.04M$ 180.08M$ 793.74M$ 66.51M
Cost of Revenue
$ 12.98M$ 8.54M$ 17.81M$ 17.93M$ 425.00K-
Gross Profit
$ 421.44M$ 240.84M$ 186.22M$ 162.15M$ 793.31M$ 66.51M
Operating Expense
$ 697.43M$ 722.86M$ 714.79M$ 796.33M$ 484.60M$ 427.84M
Operating Income
$ -273.51M$ -477.76M$ -519.62M$ -626.38M$ 308.71M$ -361.33M
Net Non Operating Interest Income Expense
$ -25.55M$ -18.79M$ -16.77M$ 2.39M$ 6.60M$ 13.73M
Other Income Expense
$ -180.21M$ -5.20M$ -6.94M$ 1.49M$ 366.00K$ 100.00K
Pretax Income
$ -127.44M$ -506.02M$ -552.28M$ -641.08M$ 314.94M$ -347.69M
Tax Provision
$ 616.00K$ 968.00K$ 5.24M$ 3.00M$ 1.06M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -129.35M$ -506.98M$ -557.52M$ -644.09M$ 313.88M$ -347.69M
Basic EPS
$ -2.07$ -8.37$ -9.35$ -11.01$ 5.76-
Diluted EPS
$ -2.12$ -8.37$ -9.35$ -11.01$ 5.59$ -7.27
Basic Average Shares
$ 248.72M$ 60.56M$ 59.64M$ 58.52M$ 54.53M$ 47.83M
Diluted Average Shares
$ 250.94M$ 60.56M$ 59.64M$ 58.52M$ 56.17M$ 47.83M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 710.41M$ 731.40M$ 732.61M$ 814.26M$ 485.03M$ 427.84M
Net Income From Continuing And Discontinued Operation
$ -128.05M$ -506.98M$ -557.52M$ -644.09M$ 313.88M$ -347.69M
Normalized Income
$ -192.41M$ -399.75M----
Interest Expense
------
EBIT
$ -124.97M$ -482.02M$ -528.57M$ -634.18M$ 308.71M$ -361.43M
EBITDA
$ -106.17M$ -470.36M$ -516.84M$ -627.70M$ 315.27M$ -356.17M
Currency in USD

Blueprint Medicines Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis